Hepatoprotective and inhibiting HBV effects of polysaccharides from roots of Sophora flavescens

Int J Biol Macromol. 2018 Mar:108:744-752. doi: 10.1016/j.ijbiomac.2017.10.171. Epub 2017 Oct 27.

Abstract

Roots of Sophora flavescens is an important herbal medicine for treatment of HBV and hepatic carcinoma in China. Alkaloids in the root were well known for exhibiting good hepato-protective and anti-HBV effects. However, polysaccharides as main components in the root remained unknown. In the studies, we investigated the chemical features and hepatoprotective effects of Sophora flavescens polysaccharides (SFP-100 and its active fractions) with ConA-induced hepatitis mice, human liver LO2 cells and HepG2.2.15 cells. The results showed that SFP-100 was composed of arabinose, glucose, galactose and galacturonic acid, SFP-100-A mainly contained glucose. SFP-100-B and SFP-100-C were acidic polysaccharides. SFP-100 significantly decreased hepatocytes apoptosis, inhibited the infiltration of neutrophils and macrophages into liver, and improved the production of IFN-γ and IL-6 of splenocytes in ConA-induced hepatitis mice. SFP-100 and its two sugar fractions increased LO2 cell proliferation and reduced cell apoptosis induced by ConA. SFP-100, SFP-100-A and SFP-100-C remarkedly inhibited the secretion of HBsAg and HBeAg by HepG2.2.15 cells.These results suggested Sophora flavescens polysaccharides exerts significant hepatoprotective and anti-HBV roles, and further is used for treatment of immune-mediated liver disease in the future.

Keywords: ConA-induced liver injury; HBV; Polysaccharides; Sophora flavescens.

MeSH terms

  • Animals
  • Antiviral Agents / chemistry
  • Antiviral Agents / pharmacology*
  • Body Weight
  • Cell Proliferation / drug effects
  • Cell Survival / drug effects
  • Chemical and Drug Induced Liver Injury / drug therapy
  • Chemical and Drug Induced Liver Injury / etiology
  • Chemical and Drug Induced Liver Injury / metabolism
  • Chemical and Drug Induced Liver Injury / pathology
  • Concanavalin A / adverse effects
  • Cytokines / metabolism
  • Disease Models, Animal
  • Female
  • Hepatitis B / drug therapy
  • Hepatitis B / pathology
  • Hepatitis B / virology
  • Hepatitis B virus / drug effects*
  • Hepatocytes / drug effects*
  • Hepatocytes / virology
  • Lymphocytes / drug effects
  • Lymphocytes / immunology
  • Lymphocytes / metabolism
  • Mice
  • Organ Size
  • Plant Extracts / chemistry
  • Plant Extracts / pharmacology*
  • Plant Roots / chemistry*
  • Polysaccharides / chemistry
  • Polysaccharides / pharmacology*
  • Protective Agents / chemistry
  • Protective Agents / pharmacology*
  • Sophora / chemistry*

Substances

  • Antiviral Agents
  • Cytokines
  • Plant Extracts
  • Polysaccharides
  • Protective Agents
  • Concanavalin A